| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.9 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.01 | 0.9 |
| mRNA | Panobinostat | FIMM | pan-cancer | AAC | 0.015 | 0.9 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |